This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Mark Chiboroski and a Patent for Viral Inactivation.
Introduction
Mark Chiboroski is an inventor associated with Ossining, New York, and Regeneron Pharmaceuticals, Inc. His patent work addresses pH control in mixtures containing polypeptides, including applications in viral inactivation.
Latest Patents
Chiboroski is associated with 1 patent, titled “Method for Viral Inactivation.” The patent describes systems and methods for adjusting the pH of a polypeptide-containing mixture. A mixture may be eluted from a chromatography column, and its protein concentration, pH, or both may be measured. Based on those measurements, the amount of acid needed to reach a target pH can be calculated and added. The pH adjustment may serve purposes such as inactivating viruses in the mixture.
Career Highlights
Chiboroski’s listed company affiliation is Regeneron Pharmaceuticals, Inc. His patent focuses on a process relevant to the handling and treatment of polypeptide mixtures.
Collaborations
John Mattila and Andrew Barmasse are identified as Chiboroski’s coworkers.
Conclusion
Mark Chiboroski’s patent describes a measured, calculated approach to pH adjustment that can support viral inactivation in polypeptide mixtures.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile